Cite

    Choi, H. et al. (2022). Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study. Pharmacoepidemiology and drug safety. 31 (11), pp. 1153-1163. [Online].